GOSS

GOSSAMER BIO INC

GOSS·38341P102·US·Common Stock·Healthcare - Biotechnology-Activist

GOSS (GOSSAMER BIO INC) is held by 100 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($5.5M), AQR CAPITAL MANAGEMENT LLC ($3.3M), VANGUARD CAPITAL MANAGEMENT LLC ($3.1M). Net institutional sentiment: Mixed.

100
Holders
(9 Elite)
$36.2M
Total Value
57% (113)
Consensus
64 buying - 49 selling
13F: Insider & Congress:
GOSSSmart Money Verdict
View all
Held by 100 funds
9 elite
Who's Trading
ActivistDED. E. Shaw Valence Portfolios, L.L.C.7.8%Jul 1, 2026
Activist68683 Capital Management, LLC10.0%Jun 11, 2026
ActivistDIDeepCurrents Investment Group LLC7.7%Jun 11, 2026
ActivistDED. E. Shaw Valence Portfolios, L.L.C.9.0%Jun 11, 2026
ActivistCOContext Capital Management, LLC9.9%Jun 9, 2026
ActivistOAOctagon Capital Advisors LP3.8%May 14, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
Activist68683 Capital Management, LLC3.9%Mar 24, 2026
ActivistGEGrowth Equity Opportunities 18 VGE, LLC1.7%Feb 24, 2026
InsiderMSMilligan SandraBuy $50KAug 19, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
16.8M(-1.4%)$5.5M0.0%-89.96%
0
Increased
10.1M(+804.8%)$3.3M0.0%-77.14%
43
New
9.4M$3.1M0.0%-63.83%
37
Increased
5.9M(+290.5%)$1.9M0.0%-84.68%
42
Unchanged
5M$1.6M0.1%-98.99%
0
Increased
4.9M(+1.4%)$1.6M0.0%-94.53%
26
Increased
4.9M(+809.7%)$1.6M0.0%-74.66%
41
Increased
4.8M(+40.7%)$1.6M0.0%-90.34%
34
Decreased
4.4M(-52.9%)$1.4M0.0%-93.33%
0
Increased
4M(+3.6%)$1.3M0.0%-94.37%
26
Increased
3.4M(+1433.8%)$1.1M0.0%-73.55%
41
Increased
3.2M(+66.5%)$1M0.0%-90.84%
37
Increased
3.1M(+431.8%)$1M0.0%-78.68%
40
New
2.2M$710,9950.0%-63.83%
38
Increased
2.1M(+125.7%)$673,8990.0%-74.58%
40
Increased
1.9M(+6.3%)$619,6990.0%-93.22%
26
Unchanged
190,220$589,6820.0%-93.81%
0
New
1.7M$559,1480.0%-63.83%
34
Decreased
1.7M(-22.2%)$556,8600.0%-91.89%
0
Increased
1.5M(+401.5%)$504,8790.0%-70.96%
39

Showing 1-20 of 118

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used